Silencing an earlier known protein could hamper tumor development and increase the efficacy of immunotherapy treatments, researchers discovered at the Bloomberg~Kimmel Institute for Cancer Immunotherapy in the Johns Hopkins Kimmel Cancer Center.
The condition of memory loss is termed as Alzheimer’s disease, affecting more than 5 million people and there is still no definite cure. A research team reported that an experimental drug could treat Alzheimer’s disease by slowing down the process of clear thinking and memory.
A prospective, observational study published in Annals of the Rheumatic Diseases, showed that patients at risk of autoimmune connective tissue disease who evolved to definite disease had high interferon levels and a family history of autoimmune rheumatic disease, foreseeing a link between the interferon scores and disease progression.
Based on studies that have revealed how specific malignancies thrive on cholesterol, and that raised serum cholesterol levels are linked to the risk of cancer and a drug compound called leelamine that has shown to retard tumor-growth in melanoma...
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.